Skandinaviska Enskilda Banken AB »

Summit Therapeutics shares owned by Skandinaviska Enskilda Banken AB

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Skandinaviska Enskilda Banken AB from 13F filings

Historical chart of Skandinaviska Enskilda Banken AB investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Skandinaviska Enskilda Banken AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Skandinaviska Enskilda Banken AB

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.0M 338k 20.66
2025-06-30 $1.4M 67k 21.26
2025-03-31 $1.3M 67k 19.31
2024-12-31 $586k 33k 17.95